Pushing Scientific Innovation from Lab to Market

Fourteen teams of Columbia faculty have been awarded a Columbia Life Science Accelerator grant to support cutting-edge translational research addressing myriad conditions and disease, including cancer, heart disease, depression, and Alzheimer’s. The recipients of the Life Science Accelerator grants are focused on research and inventions that are on a path to commercialization or the clinic via novel therapeutics discovery or technologies and devices that have the promise to change the way patients are being treated or diagnosed.

Read full article here.